Literature DB >> 19139077

SHIP prevents lipopolysaccharide from triggering an antiviral response in mice.

Laura M Sly1, Melisa J Hamilton, Etsushi Kuroda, Victor W Ho, Frann L Antignano, Stephanie L Omeis, Christina J van Netten-Thomas, Dana Wong, Hayley K Brugger, Olusegun Williams, Morris E Feldman, Benjamin T Houseman, Dorothea Fiedler, Kevan M Shokat, Gerald Krystal.   

Abstract

Gram-negative bacterial infections, unlike viral infections, do not typically protect against subsequent viral infections. This is puzzling given that lipopolysaccharide (LPS) and double-stranded (ds) RNA both activate the TIR domain-containing adaptor-inducing interferon beta (TRIF) pathway and, thus, are both capable of eliciting an antiviral response by stimulating type I interferon (IFN) production. We demonstrate herein that SH2-containing inositol-5'-phosphatase (SHIP) protein levels are dramatically increased in murine macrophages via the MyD88-dependent pathway, by up-regulating autocrine-acting transforming growth factor-beta (TGFbeta). The increased SHIP then mediates, via inhibition of the phosphatidylinositol-3-kinase (PI3K) pathway, cytosine-phosphate-guanosine (CPG)- and LPS-induced tolerance and cross-tolerance and restrains IFN-beta production induced by a subsequent exposure to LPS or dsRNA. Intriguingly, we found, using isoform-specific PI3K inhibitors, that LPS- or cytosine-phosphate-guanosine-induced interleukin-6 (IL-6) is positively regulated by p110alpha, -gamma, and -delta but negatively regulated by p110beta. This may explain some of the controversy concerning the role of PI3K in Toll-like receptor-induced cytokine production. Consistent with our in vitro findings, SHIP(-/-) mice overproduce IFN-beta in response to LPS, and this leads to antiviral hypothermia. Thus, up-regulation of SHIP in response to Gram-negative bacterial infections probably explains the inability of such infections to protect against subsequent viral infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139077      PMCID: PMC2662641          DOI: 10.1182/blood-2008-06-166082

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance.

Authors:  Laura M Sly; Michael J Rauh; Janet Kalesnikoff; Christine H Song; Gerald Krystal
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

2.  A20 is a negative regulator of IFN regulatory factor 3 signaling.

Authors:  Tatsuya Saitoh; Masahiro Yamamoto; Makoto Miyagishi; Kazunari Taira; Makoto Nakanishi; Takashi Fujita; Shizuo Akira; Naoki Yamamoto; Shoji Yamaoka
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

3.  Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling.

Authors:  Saumendra N Sarkar; Kristi L Peters; Christopher P Elco; Shuji Sakamoto; Srabani Pal; Ganes C Sen
Journal:  Nat Struct Mol Biol       Date:  2004-10-24       Impact factor: 15.369

4.  Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7.

Authors:  I Marié; J E Durbin; D E Levy
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

5.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

Review 6.  Molecular mechanisms of endotoxin tolerance.

Authors:  Hongkuan Fan; James A Cook
Journal:  J Endotoxin Res       Date:  2004

7.  Critical roles of the p110 beta subtype of phosphoinositide 3-kinase in lipopolysaccharide-induced Akt activation and negative regulation of nitrite production in RAW 264.7 cells.

Authors:  Ken Tsukamoto; Kaoru Hazeki; Megumi Hoshi; Kiyomi Nigorikawa; Norimitsu Inoue; Takehiko Sasaki; Osamu Hazeki
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

Review 8.  Signalling by PI3K isoforms: insights from gene-targeted mice.

Authors:  Bart Vanhaesebroeck; Khaled Ali; Antonio Bilancio; Barbara Geering; Lazaros C Foukas
Journal:  Trends Biochem Sci       Date:  2005-04       Impact factor: 13.807

9.  Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation.

Authors:  J E Damen; H Wakao; A Miyajima; J Krosl; R K Humphries; R L Cutler; G Krystal
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

10.  Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation.

Authors:  Ken J Ishii; Fumihiko Takeshita; Ihsan Gursel; Mayda Gursel; Jacqueline Conover; Andre Nussenzweig; Dennis M Klinman
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more
  17 in total

Review 1.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

Review 2.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

3.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

4.  Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling.

Authors:  Daniel C Peltier; Allison Simms; Jocelyn R Farmer; David J Miller
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

5.  Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways.

Authors:  Han-Fei Huang; Zhong Zeng; Kun-Hua Wang; Hai-Yan Zhang; Shuai Wang; Wen-Xiang Zhou; Zhan-Bo Wang; Wang-Gang Xu; Jian Duan
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

6.  The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.

Authors:  David Torres; Sandrine Delbauve; Ezra Aksoy; Salma Taboubi; Abderrahman Hachani; Maria A Whitehead; Wayne P Pearce; Inma M Berenjeno; Gemma Nock; Alain Filloux; Rudi Beyaert; Veronique Flamand; Bart Vanhaesebroeck
Journal:  Nat Immunol       Date:  2012-09-30       Impact factor: 25.606

7.  Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrea Faris; Adam Comstock; Wai-Ming Lee; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

8.  MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1.

Authors:  Menaka Chanu Thounaojam; Kiran Kundu; Deepak Kumar Kaushik; Shalini Swaroop; Anita Mahadevan; Susarla Krishna Shankar; Anirban Basu
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells.

Authors:  Sabine M Ivison; Mohammed A S Khan; Nicholas R Graham; Leila A Shobab; Yu Yao; Arnawaz Kifayet; Laura M Sly; Theodore S Steiner
Journal:  Mediators Inflamm       Date:  2010-10-03       Impact factor: 4.711

10.  The Crohn's disease-associated polymorphism in ATG16L1 (rs2241880) reduces SHIP gene expression and activity in human subjects.

Authors:  E N Ngoh; H K Brugger; M Monajemi; S C Menzies; A F Hirschfeld; K L Del Bel; K Jacobson; P M Lavoie; S E Turvey; L M Sly
Journal:  Genes Immun       Date:  2015-07-30       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.